Severe lung involvement in systemic scleromyxoedema: a highly unusual finding

Morales P., Martinez M.A., Vera F., Romero G.

Source: Eur Respir J 2002; 19: 976-979
Journal Issue: May

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Morales P., Martinez M.A., Vera F., Romero G.. Severe lung involvement in systemic scleromyxoedema: a highly unusual finding. Eur Respir J 2002; 19: 976-979

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Source: Eur Respir J 2009; 33: 1498-1502
Year: 2009



Emergencies in interstitial and immunological lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177
Year: 2006

Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006


Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004



Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009



Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005



Interstitial lung diseases in childhood
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213
Year: 2002

Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012


Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008



Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012



Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002



Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011


The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012



Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Dendriform pulmonary ossification as a rare and unusual complication associated with interstitial lung disease
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020